title: O-GlcNAcylation and the Metabolic Shift in High-Proliferating Cells: All the Evidence Suggests that Sugars Dictate the Flux of Lipid Biogenesis in Tumor Processes.
abstract: Cancer cells are characterized by their high capability to proliferate. This imposes an accelerated biosynthesis of membrane compounds to respond to the need for increasing the membrane surface of dividing cells and remodeling the structure of lipid microdomains. Recently, attention has been paid to the upregulation of O-GlcNAcylation processes observed in cancer cells. Although O-GlcNAcylation of lipogenic transcriptional regulators is described in the literature (e.g., FXR, LXR, ChREBP), little is known about the regulation of the enzymes that drive lipogenesis: acetyl co-enzyme A carboxylase and fatty acid synthase (FAS). The expression and catalytic activity of both FAS and O-GlcNAc transferase (OGT) are high in cancer cells but the reciprocal regulation of the two enzymes remains unexplored. In this perspective, we collected data linking FAS and OGT and, in so doing, pave the way for the exploration of the intricate functions of these two actors that play a central role in tumor growth.
authors.affiliation: University Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle , Lille , France.
authors.forename: Steffi F
authors.initials: SF
authors.lastname: Baldini
authors.affiliation: University Lille, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle , Lille , France.
authors.forename: Tony
authors.initials: T
authors.lastname: Lefebvre
keywords: FAS; O-GlcNAcylation; OGT; cancer; cell proliferation
references.citation: Mol Biol Rep. 2011 Jan;38(1):553-9
references.pmid: 20373033
references.citation: Cancer Res. 2010 Aug 1;70(15):6344-51
references.pmid: 20610629
references.citation: J Biol Chem. 2007 Sep 14;282(37):26793-801
references.pmid: 17635921
references.citation: Physiology (Bethesda). 2015 Nov;30(6):428-37
references.pmid: 26525342
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: FASEB J. 2013 Sep;27(9):3478-86
references.pmid: 23689613
references.citation: Cancer Res. 2006 Sep 1;66(17):8625-32
references.pmid: 16951176
references.citation: Mol Cell Proteomics. 2013 Dec;12(12):3489-97
references.pmid: 23824911
references.citation: Cancer Res. 2003 Nov 1;63(21):7330-7
references.pmid: 14612531
references.citation: J Biol Chem. 2014 Apr 11;289(15):10592-606
references.pmid: 24563466
references.citation: Biochim Biophys Acta. 2011 Apr;1812(4):514-9
references.pmid: 21255644
references.citation: J Biol Chem. 2001 Mar 30;276(13):9838-45
references.pmid: 11148210
references.citation: Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):358-65
references.pmid: 16778563
references.citation: Oncogene. 2010 May 13;29(19):2831-42
references.pmid: 20190804
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3450-4
references.pmid: 10716717
references.citation: Cancer Res. 2006 Mar 15;66(6):3006-14
references.pmid: 16540649
references.citation: Cell Metab. 2012 Aug 8;16(2):226-37
references.pmid: 22883232
references.citation: J Biol Chem. 2008 Feb 8;283(6):3418-23
references.pmid: 18056116
references.citation: Clin Cancer Res. 1997 Nov;3(11):2115-20
references.pmid: 9815604
references.citation: Biochim Biophys Acta. 2005 Feb 21;1687(1-3):141-51
references.pmid: 15708362
references.citation: Cancer Cell. 2004 Mar;5(3):253-61
references.pmid: 15050917
references.citation: J Biol Chem. 1975 Jun 25;250(12):4520-9
references.pmid: 237903
references.citation: Nature. 2008 Feb 21;451(7181):964-9
references.pmid: 18288188
references.citation: Biochem Biophys Res Commun. 2003 Mar 21;302(4):898-903
references.pmid: 12646257
references.citation: Cell Metab. 2007 Jan;5(1):73-9
references.pmid: 17189208
references.citation: J Biol Chem. 2010 Jan 15;285(3):1607-15
references.pmid: 19933273
references.citation: Cancer Res. 2010 Oct 15;70(20):8117-26
references.pmid: 20876798
references.citation: FASEB J. 2014 Aug;28(8):3325-38
references.pmid: 24744147
references.citation: Mol Biol Cell. 2008 Oct;19(10):4130-40
references.pmid: 18653473
references.citation: Cancer Res. 2005 Aug 1;65(15):6719-25
references.pmid: 16061653
references.citation: FEBS Lett. 2008 Jan 9;582(1):68-73
references.pmid: 17716660
references.citation: PLoS One. 2009 Aug 27;4(8):e6812
references.pmid: 19710915
references.citation: J Natl Cancer Inst. 2009 Apr 1;101(7):519-32
references.pmid: 19318631
references.citation: J Biol Chem. 2007 Jan 5;282(1):743-51
references.pmid: 17107947
references.citation: J Biol Chem. 2010 Dec 3;285(49):38684-91
references.pmid: 20926386
references.citation: Biochim Biophys Acta. 1999 Oct 18;1472(1-2):71-81
references.pmid: 10572927
references.citation: J Biol Chem. 2013 Feb 8;288(6):3823-30
references.pmid: 23269672
references.citation: Genes Dev. 2000 Nov 15;14 (22):2819-30
references.pmid: 11090130
references.citation: Nutrition. 2000 Mar;16(3):202-8
references.pmid: 10705076
references.citation: Int J Cancer. 2015 May 1;136(9):2078-90
references.pmid: 25302649
references.citation: Breast Cancer Res. 2010;12(6):R96
references.pmid: 21080941
references.citation: J Cell Physiol. 2012 Jan;227(1):108-15
references.pmid: 21374590
references.citation: J Biol Chem. 2013 May 24;288(21):15121-30
references.pmid: 23592772
references.citation: J Biol Chem. 1994 Feb 4;269(5):3858-67
references.pmid: 8106431
references.citation: Med Oncol. 2012 Jun;29(2):985-93
references.pmid: 21461968
references.citation: Diabetes. 2011 May;60(5):1399-413
references.pmid: 21471514
references.citation: Anticancer Res. 2004 Nov-Dec;24(6):4169-73
references.pmid: 15736468
references.citation: Biotechnol Appl Biochem. 2016 Nov;63(6):841-851
references.pmid: 26333304
references.citation: J Cutan Pathol. 2003 Jan;30(1):23-8
references.pmid: 12534800
references.citation: Int J Mol Sci. 2015 Sep 03;16(9):21138-52
references.pmid: 26404259
references.citation: Diabetes. 2004 Dec;53 Suppl 3:S84-91
references.pmid: 15561928
references.citation: Cell Cycle. 2008 Jul 15;7(14):2257-67
references.pmid: 18635971
references.citation: J Clin Invest. 2002 May;109(9):1125-31
references.pmid: 11994399
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21660-5
references.pmid: 19995986
references.citation: Traffic. 2004 Apr;5(4):247-54
references.pmid: 15030566
references.citation: J Lipid Res. 2015 Apr;56(4):771-85
references.pmid: 25724563
references.citation: J Biol Chem. 1979 Aug 10;254(15):7418-26
references.pmid: 457689
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13793-8
references.pmid: 18779572
references.citation: Mol Cell Proteomics. 2007 Aug;6(8):1365-79
references.pmid: 17507370
references.citation: Am J Physiol Endocrinol Metab. 2012 Feb 15;302(4):E417-24
references.pmid: 22114026
references.citation: Leukemia. 2010 Sep;24(9):1588-98
references.pmid: 20668475
references.citation: J Biol Chem. 1997 Apr 4;272(14):9308-15
references.pmid: 9083067
references.citation: Adv Biol Regul. 2015 Jan;57:130-46
references.pmid: 25465296
references.citation: Biochem Biophys Res Commun. 2010 Nov 26;402(4):784-9
references.pmid: 21036147
references.citation: Biochim Biophys Acta. 2010 Feb;1800(2):67-79
references.pmid: 19732809
references.citation: Science. 2012 Aug 24;337(6097):975-80
references.pmid: 22923583
references.citation: J Biol Chem. 1991 Mar 15;266(8):4706-12
references.pmid: 2002019
references.citation: Hepatology. 2014 May;59(5):2022-33
references.pmid: 24037988
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98 (24):13710-5
references.pmid: 11698644
references.citation: Int J Cancer. 2002 Mar 1;98(1):19-22
references.pmid: 11857379
references.citation: Trends Endocrinol Metab. 2013 May;24(5):257-68
references.pmid: 23597489
references.citation: Clin Lab. 2012;58(5-6):579-83
references.pmid: 22783592
references.citation: Am J Pathol. 1997 Jan;150(1):201-8
references.pmid: 9006336
references.citation: Int J Oncol. 2014 Aug;45(2):485-92
references.pmid: 24827738
references.citation: Cancer Biol Ther. 2010 Sep 15;10(6):549-54
references.pmid: 20657182
references.citation: J Biol Chem. 2012 Aug 17;287(34):28755-69
references.pmid: 22730328
references.citation: Anticancer Res. 2007 Jul-Aug;27(4B):2523-7
references.pmid: 17695548
references.citation: Histopathology. 2002 Jan;40(1):71-9
references.pmid: 11903600
references.citation: J Biol Chem. 2012 Mar 30;287(14 ):11070-81
references.pmid: 22275356
references.citation: J Biol Chem. 2008 Aug 1;283(31):21411-7
references.pmid: 18519567
references.citation: J Biol Chem. 1984 Mar 10;259(5):3308-17
references.pmid: 6421821
references.citation: Br J Cancer. 1979 Jun;39(6):681-7
references.pmid: 444407
references.citation: J Biol Chem. 2009 Jan 2;284(1):547-55
references.pmid: 19004814
references.citation: Mol Cell Biol. 2013 Jun;33(11):2202-11
references.pmid: 23530060